Found: 13
Select item for more details and to access through your institution.
Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility.
- Published in:
- Molecular Biology Reports, 2011, v. 38, n. 4, p. 2295, doi. 10.1007/s11033-010-0361-2
- By:
- Publication type:
- Article
Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 124, n. 2, p. 419, doi. 10.1007/s10549-010-0846-7
- By:
- Publication type:
- Article
MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 123, n. 2, p. 549, doi. 10.1007/s10549-010-0783-5
- By:
- Publication type:
- Article
Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2015, v. 34, n. 1, p. 1, doi. 10.1186/s13046-015-0194-x
- By:
- Publication type:
- Article
Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 103, doi. 10.1007/s00280-012-1983-y
- By:
- Publication type:
- Article
Hepatic Lesions Detected after Mastectomy, in Breast Cancer Patients with Hepatitis Background May Need to Undergo Liver Biopsy to Rule Out Second Primary Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0139782
- By:
- Publication type:
- Article
Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple‐negative breast cancer to immune checkpoint inhibitors.
- Published in:
- Cancer Communications, 2023, v. 43, n. 9, p. 1003, doi. 10.1002/cac2.12465
- By:
- Publication type:
- Article
Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00462-6
- By:
- Publication type:
- Article
The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.
- Published in:
- Medical Oncology, 2015, v. 32, n. 11, p. 1, doi. 10.1007/s12032-015-0696-6
- By:
- Publication type:
- Article
Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-232
- By:
- Publication type:
- Article
The maximum standardized uptake value of <sup>18</sup> F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-42
- By:
- Publication type:
- Article
The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients.
- Published in:
- 2013
- By:
- Publication type:
- journal article